Another meta-analysis of randomized controlled trials found that endothelial function in normal-weight and overweight but not obese patients with type 2 diabetes was significantly improved by supplementation with vitamin E and/or vitamin C (90)
Why Precision Dosing and Genetic Testing Reduce Overdose Risk PlexusDx Precision Peptide Genetic Test identifies individual variations in GLP-1 receptor function and metabolic pathways, revealing whether a patient has genetic variants that increase sensitivity to GLP-1 agonists
Ultra-Processed Foods and Added Sugar Crisps, biscuits, breakfast cereals with added sugar, pastries, doughnuts, ice cream, and sugary drinks (regular soda, energy drinks, sweetened juice) spike blood glucose rapidly and trigger nausea
Target RWE's MASLD and MASH patient cohorts have expanded with the broad TARGET-LIVER DISEASE (TARGET-LD) observational real-world study protocol that collects complete patient data from health systems in the U.S
lowest tolerated dose Phase Step 2 Weeks Weeks 5-8 Cagrilintide Dose 0.5 mg/week Purpose Dose escalation Phase Step 3 Weeks Weeks 9-12 Cagrilintide Dose 1.0 mg/week Purpose GI side effects often peak here Phase Step 4 Weeks Weeks 13-16 Cagrilintide Dose 1.7 mg/week Purpose Approaching maintenance Phase Maintenance Weeks Weeks 17+ Cagrilintide Dose 2.4 mg/week Purpose Target dose used in late-stage study protocols Each step lasts 4 weeks
Dietary modifications work synergistically with tirzepatide's appetite-suppressing effects
